Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabien Calcagno
Observed names:
Calcagno Fabien,
F. Calcagno
Institution:
Centre Hospitalier Universitaire de Besançon
Observed institutions:
Inserm,
Assistance Publique Hôpitaux de Marseille,
Centre Hospitalier Universitaire de Besançon,
Université Bourgogne Franche-Comté,
Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique,
Université de Franche-Comté
show all 6
ORCID:
0000-0003-1455-3776
Observed ORCID:
0000-0003-1455-3776
OpenAlex ID:
A5038095307
Ex Vivo Pretreatment with Melatonin Improves Survival, Proangiogenic/Mitogenic Activity, and Efficiency of Mesenchymal Stem Cells Injected into Ischemic Kidney
2008
·
Céline Mias
, Elodie Trouche
, et al.
·
Stem Cells
·
218
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
2023
·
A.O. Siefker-Radtke
, N. Matsubara
, et al.
·
Annals of Oncology
·
103
PDF
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
2018
·
Claire Merveilleux du Vignaux
, Eric Dansin
, et al.
·
Journal of Thoracic Oncology
·
92
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
2016
·
Fabien Calcagno
, Sabrina Lenoble
, et al.
·
Clinical Medicine Insights Oncology
·
30
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice
2021
·
Guillaume Mouillet
, Antoine Falcoz
, et al.
·
Quality of Life Research
·
28
Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer
2012
·
Fabien Calcagno
, Thierry Nguyen
, et al.
·
Clinical Medicine Insights Oncology
·
23
Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review
2020
·
Elodie Klajer
, Louis Garnier
, et al.
·
Seminars in Oncology
·
22
PDF
Safety profile of new anticancer drugs
2010
·
Laura Mansi
, Antoine Thiery-Vuillemin
, et al.
·
Expert Opinion on Drug Safety
·
22
Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network
2021
·
Arthur Petat
, Eric Dansin
, et al.
·
European Journal of Cancer
·
20
PDF
FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
2020
·
Angélique Vienot
, Hortense Chevalier
, et al.
·
World Journal of Gastrointestinal Oncology
·
20
PDF
Metronomic cyclophosphamide induces regulatory T cells depletion and PSA‐specific T cells reactivation in patients with biochemical recurrent prostate cancer
2019
·
Caroline Laheurte
, Antoine Thiery‐Vuillemin
, et al.
·
International Journal of Cancer
·
20
PDF
Génotypage moléculaire dans les cancers réfractaires de la thyroïde en 2021 : quand, comment, et pourquoi ? Un travail du réseau TUTHYREF
2021
·
Christelle de la Fouchardière
, Johanna Wassermann
, et al.
·
Bulletin du Cancer
·
16
PDF
Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE
2020
·
Noémie Gassian
, Alexandre Frontczak
, et al.
·
Bulletin du Cancer
·
16
PDF
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma
2017
·
Antoine Thiery-Vuillemin
, Emeline Orillard
, et al.
·
Cancer Chemotherapy and Pharmacology
·
15
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report
2017
·
Guillaume Meynard
, Laura Mansi
, et al.
·
Oncology Reports
·
15
PDF
Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice
2017
·
Antoine Thiery-Vuillemin
, Tiphaine Cholley
, et al.
·
Clinical Genitourinary Cancer
·
12
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
2018
·
Guillaume Mouillet
, Marie-Justine Paillard
, et al.
·
Trials
·
11
PDF
Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial
2016
·
Fabien Calcagno
, Guillaume Mouillet
, et al.
·
Medical Oncology
·
8
Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study
2024
·
P. Barthélémy
, L. Albigès
, et al.
·
ESMO Open
·
7
Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies
2018
·
Tiphaine Cholley
, Antoine Thiery-Vuillemin
, et al.
·
Clinical Genitourinary Cancer
·
7
PDF
Central Nervous System Metastases in Thymic Epithelial Tumors: A Brief Report of Real-World Insight From RYTHMIC
2021
·
Jose Carlos Benitez
, Marie-Ève Boucher
, et al.
·
Journal of Thoracic Oncology
·
6
PDF
53P Studying autoimmune diseases with thymic epithelial tumors (TET): Real-world insight from RYTHMIC
2020
·
J.C. Benitez
, M-E. Boucher
, et al.
·
Annals of Oncology
·
5
1899P Autoimmune diseases in centrally reviewed thymic epithelial tumours (TET)
2020
·
J.C. Benitez Montanez
, M-É. Boucher
, et al.
·
Annals of Oncology
·
5
Traitement systémique du cancer du pénis localement avancé ou métastatique
2020
·
Noémie Gassian
, Alexandre Frontczak
, et al.
·
Bulletin du Cancer
·
5
PDF
Prevalence of autoimmune diseases in thymic epithelial tumors (TET) insights from RYTHMIC.
2020
·
Jose Carlos Benitez
, Marie Eve Boucher
, et al.
·
Journal of Clinical Oncology
·
5
Show more works
View as search
Works count:
56
Citation count:
750
H-index:
15
I10-index:
17
Year
Topic
Type